Baltimore, MD, United States of America

Verena Staedtke

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Verena Staedtke

Introduction

Verena Staedtke is a prominent inventor based in Baltimore, MD, known for her groundbreaking contributions to medical research and oncolytic therapies. With a total of four patents to her name, Staedtke's work showcases her dedication to improving treatment options for cancer patients through innovative approaches.

Latest Patents

Among her latest patents, two notable inventions stand out:

1. **Neutrophil suppression as preconditioning to increase oncolytic bacterial therapy** - This invention presents methods to enhance the therapeutic efficiency of oncolytic bacterial treatments. The study investigates immune-modulating preconditioning to suppress host neutrophils, resulting in significantly better antitumor efficacy in animal models. The clinically approved preconditioning agent, hydroxyurea, has shown promising safety profiles and antitumor responses in clinical trials, making the proposed method translatable to patients undergoing oncolytic bacterial therapy.

2. **Preventative effect of mebendazole against malignancies in neurofibromatosis** - This invention provides innovative methods for delaying or preventing NF1-related malignancies using the medication mebendazole. The invention highlights decreased Ras activation in NF1-related tumor cells and suggests using a cyclooxygenase-2 inhibitor, such as celecoxib, in combination with mebendazole to enhance treatment outcomes.

Career Highlights

Verena Staedtke works at The Johns Hopkins University, where she contributes to cutting-edge research in oncology and immunology. Her commitment to improving patient outcomes through innovative treatments has established her as a notable figure in her field.

Collaborations

Staedtke has collaborated with esteemed colleagues such as Renyuan Bai and Gregory J. Riggins, enhancing the quality and depth of her research. These partnerships highlight the collaborative spirit within the scientific community and the importance of teamwork in driving innovation.

Conclusion

Through her inventive approaches and significant contributions to the field of cancer therapy, Verena Staedtke exemplifies the impact that dedicated inventors can have on improving health outcomes. Her work continues to inspire future innovations and advancements in medical treatment, demonstrating the transformative power of creative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…